Global Health Share Price
Small Cap | Pharmaceuticals and health care | NSE: MEDANTA | BSE: 543654
₹1,160.00 
5.60 (0.49 %)
Last Updated: 06 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 1,152.10
High (₹) 1,171.00
Low (₹) 1,130.00
Prev. Close (₹) 1,154.40
Volume 35,066
VWAP (₹) 1,132.52
ROCE (%) 19.01
Industry P/E 98.88
TTM P/E 61.41
P/B Ratio 10.80
Market Cap (₹) Cr.31,384.44
Dividend Yield (%)--
EPS (₹) 17.8
ROE16.45%
Sales Growth (%) 21.56
Profit Growth (%)46.61
Day Range
1,171.001,171.00
52 Week Range
936.051,513.75
Historical Returns
Returns (6M)
7.13 %
Returns (1Y)
-6.25 %
Returns (3Y)
179.08 %
Returns (5Y)
179.08 %
Returns (6M)
7.13 %
Returns (1Y)
-6.25 %
Returns (3Y)
179.08 %
Returns (5Y)
179.08 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (41.61%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 41.61% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- High CCI indicates strong upward momentum.
- Positive ROC (9) indicates upward momentum.
- Strong trend indicated by ADX above 25.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
BEARISHRSI 73.8
MFI 68.9
ATR 47.96
Commodity Channel Index 298.8
ROC125 -2.37
ROC21 8
Williams %R -7.68
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 1,194.51 | 1,234.63 | 1,301.61 | 1,127.53 | 1,087.41 | 1,020.43 | 980.31 |
| Week Ago | 1,035.86 | 1,055.43 | 1,072.86 | 1,018.43 | 998.86 | 981.43 | 961.86 |
| Month Ago | 1,108.84 | 1,127.57 | 1,139.19 | 1,097.22 | 1,078.49 | 1,066.87 | 1,048.14 |
EMA & SMA
1160.00
Current Price
Bullish Moving Averages
19
Bearish Moving Averages
1
5 Day 1061.85
9 Day 1046.88
10 Day 1051.64
12 Day 1053.98
14 Day 1043.43
20 Day 1048.56
26 Day 1056.21
50 Day 1084.55
100 Day 1075.25
200 Day 1161.18
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| JM FINANCIAL INSTITUTIONAL SECURITIES LIMITED | bulk | Sell | 14 Feb, 2024 | ₹1,315.05 | 30,00,000 | BSE |
| DUNEARN INVESTMENTS MAURITIUS PTE LIMITED | bulk | Sell | 14 Feb, 2024 | ₹1,315.2 | 30,00,000 | BSE |
| RJ CORP LIMITED | bulk | Buy | 14 Feb, 2024 | ₹1,315 | 28,82,203 | BSE |
| JM FINANCIAL INSTITUTIONAL SECURITIES LIMITED | bulk | Buy | 14 Feb, 2024 | ₹1,315.22 | 30,00,000 | BSE |
| JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITED | block | Sell | 18 Jan, 2024 | ₹1,030.05 | 2,97,792 | BSE |
| THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT | block | Buy | 18 Jan, 2024 | ₹1,030.05 | 2,97,792 | BSE |
Insider Trading
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 05 Feb, 2025 | BSE India | Intimation for Audio Recording Link for Earning Conference Call held on February 5, 2025. |
| 05 Feb, 2025 | BSE India | Intimation for Credit Rating |
| 04 Feb, 2025 | NSE India | Global Health Limited has informed the Exchange about Presentation |
| 04 Feb, 2025 | NSE India | Global Health Limited has informed the Exchange regarding a press release dated February 04, 2025, titled ""Press Release, for the third quarter and nine months ended December 31, 2024 Results."". |
| 04 Feb, 2025 | BSE India | Investor Presentation for the third quarter and nine months ended December 31, 2024. |
| 04 Feb, 2025 | BSE India | Press Release for the third quarter and nine months ended December 31, 2024 Results. |
| 04 Feb, 2025 | BSE India | Integrated Filing (Financial) for quarter and nine months ended December 31, 2024. |
| 04 Feb, 2025 | BSE India | Recommendation to the members for reappointment of Ms. Praveen Mahajan (DIN: 07138514) as an Independent Director of the Company for the period of 5 years. |
| 04 Feb, 2025 | NSE India | GLOBAL HEALTH LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| 04 Feb, 2025 | NSE India | Global Health Limited has informed the Exchange regarding Change in Director(s) of the company. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 22 Jan, 2025 | 04 Feb, 2025 |
| Quarterly Results | -- | 08 Nov, 2024 | 14 Nov, 2024 |
| Quarterly Results | -- | 01 Aug, 2024 | 08 Aug, 2024 |
| Audited Results | -- | 08 May, 2024 | 17 May, 2024 |
| Quarterly Results | -- | 31 Jan, 2024 | 08 Feb, 2024 |
| Quarterly Results | -- | 31 Oct, 2023 | 09 Nov, 2023 |
| Quarterly Results | -- | 03 Aug, 2023 | 10 Aug, 2023 |
| Audited Results | -- | 22 May, 2023 | 27 May, 2023 |
| Quarterly Results | -- | 07 Feb, 2023 | 13 Feb, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Global Health
Global Health is a Public Limited Listed company incorporated on 13/08/2004 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L85110DL2004PLC128319 and registration number is 128319. Currently Company is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 2280.01 Cr. and Equity Capital is Rs. 53.70 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
2004
Managing Director
Dr. Naresh Trehan
NSE Symbol
MEDANTA
Global Health Management
| Name | Designation |
|---|---|
| Dr. Naresh Trehan | Chairman & Managing Director |
| Mr. Sunil Sachdeva | Non Executive Director |
| Mr. Ravi Kant Jaipuria | Non Exe. & Nominee Director |
| Mr. Venkatesh Ratnasami | Non Exe. & Nominee Director |
| Mr. Pankaj Sahni | Director & Group CFO |
| Mr. Vikram Singh Mehta | Independent Director |
| Mr. Hari Shanker Bhartia | Independent Director |
| Mr. Rajan Bharti Mittal | Independent Director |
| Dr. Ravi Gupta | Independent Director |
| Ms. Praveen Mahajan | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Max Heal.Ins | ₹1,09,500.95 | ₹1,125.75  ₹1,169.70(-3.76%) | ₹669.650 - ₹1,215.000 |
| Apollo Hspt | ₹1,04,190.68 | ₹6,874.25 ₹6,944.65(-1.01%) | ₹5,639.700 - ₹7,545.100 |
| Fortis Healt | ₹51,495.70 | ₹651.10 ₹669.70(-2.78%) | ₹375.100 - ₹740.100 |
| GlobalHealth | ₹29,286.77 | ₹1,168.50  ₹1,152.90(1.35%) | ₹930.000 - ₹1,513.750 |
| Narayana Hru | ₹26,515.81 | ₹1,373.70 ₹1,356.10(1.30%) | ₹1,087.800 - ₹1,445.050 |
FAQs on Global Health
What is the share price of Global Health?
The share price of Global Health on 06 Feb, 2025 is ₹ 1,160.00.
What is 52W high and 52W low share price of Global Health?
The highest and lowest 52W share prices of Global Health are ₹ 1513.750 and ₹ 930.000
What is the market cap of Global Health?
The market capitalization of Global Health as of 06 Feb, 2025 is ₹ 31,384.44 Crores
What is the P/E ratio of Global Health?
The current P/E ratio of Global Health as of 06 Feb, 2025 is 98.88
What is the PB ratio of Global Health?
The PB ratio of Global Health as of 06 Feb, 2025 is 10.80
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)